Botulinum toxin treatment in craniofacial, inguinal, palmar, plantar and truncal hyperhidrosis, a randomized, double blind, placebo controlled study.

Svettmottagningen Hidroskliniken, Stockholm0 个研究点开始时间: 2011年7月19日最近更新: 2014年12月1日

适应症

试验速览

暂无简介。

•The following inclusion criteria must be fulfilled prior to inclusion of the patient in the study:
•Informed consent received from patient
•Hyperhidrosis of the head, trunk, groins/buttocks, hands or feet
•Age > 16 years
•Patients must be previously untreated with Btx A/B
•If female, patient is post-menopausal, surgically sterilized, or willing to use an acceptable method of birth control
•Patients must have DLQI-score = 10 and HDSS-score = 3 to be included in the study
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•If any of the below listed exclusion criteria are fulfilled, the patient must NOT be included in the study:
•Contraindication to Btx
•Use of aminoglycosides, tetracyklines , spectinomycin, lincomycin, polymyxin or muscle relaxants
•Pregnancy or lactation
•Patients unwilling to meet the requirements of the protocol

发起方

Svettmottagningen Hidroskliniken, Stockholm